Publications by authors named "David B Sewell"
Article Synopsis
- Esophagectomy is the standard treatment for early-stage esophageal cancer, with minimally invasive techniques like MIE showing benefits over traditional surgery since the 1990s.
- Robotic-assisted MIE (RAMIE) was developed in 2004 to further improve outcomes, but its high costs and complexity have limited widespread use and definitive studies backing its advantages.
- Despite being a newer method, RAMIE appears feasible with outcomes comparable to other techniques, along with positive effects on patient satisfaction and quality of life.
Background: More than one-half of patients treated with esophagectomy for esophageal cancer experience recurrence. Oligometastasis, a proposed intermediate state of isolated local or solid organ recurrence that occurs before widespread systemic disease, is a potential target for aggressive local intervention. This study investigated presentation and prognosis among solid organ recurrence sites.
View Article and Find Full Text PDFBackground: Induction therapy has not been proven to be beneficial for patients with clinical T2N0 esophageal adenocarcinoma. Surgery alone is associated with disappointing survival for patients found to have nodal disease on final pathologic examination. The aim of this study was to identify factors that predict pathologic nodal involvement in patients with endoscopic ultrasound (EUS)-proven T2N0 esophageal adenocarcinoma.
View Article and Find Full Text PDFBackgrounds And Aims: As treatment for esophageal cancer often involves a multidisciplinary approach, the initial endoscopic report is essential for communication between providers. Several guidelines have been established to standardize endoscopic reporting. This study evaluates the compliance of esophagogastroduodenoscopy (EGD) and endoscopic ultrasound (EUS) reporting with the current national guidelines.
View Article and Find Full Text PDFBackground: In the USA, a quarter of elderly patients do not receive any treatment for regional gastric cancer, which results in poorer outcomes. We sought to identify factors associated with undertreatment of regional gastric cancer in this population, as well as to assess overall survival in the undertreated population.
Methods: Elderly patients (aged ≥ 65 years) diagnosed with regional gastric cancer between 2001 and 2009 were identified from the Surveillance Epidemiology and End Results (SEER)-Medicare linked databases.